List view / Grid view
11 September 2015 | By Victoria White
Researchers have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry experiments...
11 September 2015 | By Victoria White
The new technique could cut the potential for side effects and help usher kinase inhibitors past strict regulatory hurdles...
11 September 2015 | By Victoria White
Researchers have discovered why long-term use of levodopa, a treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia...
11 September 2015 | By Victoria White
Researchers have developed the user-friendly technology to help scientists understand how proteins work and fix them when they are broken...
11 September 2015 | By Victoria White
Gencia and Takeda aim to jointly research and develop two preclinical drug candidates, one each in the areas of inflammation and oncology...
10 September 2015 | By Victoria White
The SAS1B protein appears only on egg cells and cancer cells, and could serve as a target for tiny tracking probes created using monoclonal antibodies...
10 September 2015 | By Victoria White
MGB Biopharma was one of three shortlisted finalists for the “Early Stage/ Risk Capital Deal of the Year” category which is awarded for a deal made by an early stage company...
10 September 2015 | By Victoria White
BLU-285 is a potent and highly selective inhibitor of the KIT D816V mutant, the primary driver of disease in more than 94% of systemic mastocytosis patients...
10 September 2015 | By Victoria White
Administration of human umbilical cord blood cell-derived monocytes diminished Aβ pathology in test models and also improved hippocampal-dependent learning, memory and motor function...
9 September 2015 | By Victoria White
Scientists from Leuphana University Lüneburg have developed a way to make drugs that break down into harmless compounds before they contaminate our water supply...
9 September 2015 | By Victoria White
In vivo administration of Col-Treg in the model of autoimmune uveitis significantly inhibited clinical symptoms, retinal tissue lesions as well as ocular proinflammatory cell infiltration...
9 September 2015 | By Victoria White
New research suggests genetic inheritance is much more important in testicular cancer than in most other cancer types, where genetics typically accounts for less than 20% of risk...
8 September 2015 | By Victoria White
A University of Birmingham research team, developing a treatment for Wolfram Syndrome, has secured £17,000 from the Enterprising Birmingham Fund...
8 September 2015 | By Victoria White
AMRA will collaborate with Pfizer to help provide a better understanding of the relationship between body composition and risk for obesity related diseases...
8 September 2015 | By Victoria White
Addex Therapeutics has granted an option to license its metabotropic glutamate receptor subtype 3 (mGlu3 receptor) programme to Pierre Fabre...
